Growth Metrics

RAPT Therapeutics (RAPT) Non-cash Items (2020 - 2024)

Historic Non-cash Items for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $3000.0.

  • Therapeutics' Non-cash Items fell 9995.08% to $3000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $3000.0, marking a year-over-year decrease of 9995.08%. This contributed to the annual value of $23.2 million for FY2023, which is 14621.75% up from last year.
  • Per Therapeutics' latest filing, its Non-cash Items stood at $3000.0 for Q3 2024, which was down 9995.08% from $49000.0 recorded in Q2 2024.
  • Therapeutics' 5-year Non-cash Items high stood at $38.4 million for Q4 2021, and its period low was $3000.0 during Q3 2024.
  • Over the past 5 years, Therapeutics' median Non-cash Items value was $11.1 million (recorded in 2020), while the average stood at $13.7 million.
  • In the last 5 years, Therapeutics' Non-cash Items skyrocketed by 24538.34% in 2021 and then plummeted by 9995.08% in 2024.
  • Therapeutics' Non-cash Items (Quarter) stood at $11.1 million in 2020, then surged by 245.38% to $38.4 million in 2021, then tumbled by 75.47% to $9.4 million in 2022, then skyrocketed by 146.22% to $23.2 million in 2023, then plummeted by 99.99% to $3000.0 in 2024.
  • Its Non-cash Items stands at $3000.0 for Q3 2024, versus $49000.0 for Q2 2024 and $1.3 million for Q1 2024.